STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$12.70
−9.93%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- $0.24
- Revenue estimate
- $412.1M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- $0.18
- EPS estimate
- $0.18
- Revenue actual
- $369.8M
- Revenue estimate
- $363.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +6.3%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | $0.18 | $0.18 | Beat 1.41% | $369.4M |
| Aug 4, 2026 | $0.14 | $0.16 | Beat 10.50% | $344.9M |
| May 7, 2026 | $0.12 | $0.13 | Beat 8.33% | $316.1M |
| Mar 4, 2026 | $0.20 | $0.21 | Beat 5.00% | $403.2M |
| Nov 6, 2025 | $0.14 | $0.16 | Beat 14.29% | $355.1M |
| May 8, 2025 | $0.10 | $0.11 | Beat 10.00% | $281.3M |
| Mar 6, 2025 | $0.20 | $0.20 | In line | $342.3M |
| May 9, 2024 | $0.12 | $0.09 | Miss -27.28% | $253.5M |
| Mar 7, 2024 | $0.21 | $0.20 | Miss -5.25% | $352.6M |
| Oct 31, 2023 | $0.16 | $0.16 | In line | $286.3M |
| Jul 28, 2023 | $0.14 | $0.15 | Beat 7.68% | $278.5M |
| May 4, 2023 | $0.13 | $0.12 | Miss -8.32% | $258.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027